CRMD insider transaction filings
CorMedix Inc. — 41 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-02-06. Screen CRMD transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-06 | 4 | Zelnick Kaufman Beth — Chief Legal Officer | Grant/award (A): 36,006 @ $0 | EDGAR |
| 2026-02-06 | 4 | Hurlburt Elizabeth — Chief Operating Officer | Grant/award (A): 36,006 @ $0 | EDGAR |
| 2026-02-06 | 4 | Todisco Joseph — Chief Executive Officer, Director | Grant/award (A): 77,156 @ $0 | EDGAR |
| 2026-01-27 | 4 | Blum Susan — Chief Financial Officer | Grant/award (A): 72,820 @ $0 · Tax withholding (F): 9,767 @ $7.27 | EDGAR |
| 2026-01-27 | 4 | Zelnick Kaufman Beth — Chief Legal Officer | Grant/award (A): 72,820 @ $0 · Tax withholding (F): 8,803 @ $7.27 | EDGAR |
| 2026-01-27 | 4 | Hurlburt Elizabeth — Chief Operating Officer | Grant/award (A): 93,010 @ $0 · Tax withholding (F): 10,778 @ $7.27 | EDGAR |
| 2026-01-27 | 4 | Todisco Joseph — Chief Executive Officer, Director | Grant/award (A): 225,900 @ $0 · Tax withholding (F): 27,306 @ $7.27 | EDGAR |
| 2026-01-27 | 4 | Stewart Robert A — Director | Grant/award (A): 30,453 @ $0 | EDGAR |
| 2026-01-27 | 4 | Dillione Janet — Director | Grant/award (A): 30,453 @ $0 | EDGAR |
| 2026-01-27 | 4 | Kaplan Myron — Director | Grant/award (A): 30,453 @ $0 | EDGAR |
| 2026-01-27 | 4 | Duncan Gregory Scott — Director | Grant/award (A): 30,453 @ $0 | EDGAR |
| 2026-01-27 | 4 | Lefkowitz Steven W — Director | Grant/award (A): 30,453 @ $0 | EDGAR |
| 2026-01-27 | 4 | DUNTON ALAN W — Director | Grant/award (A): 30,453 @ $0 | EDGAR |
| 2026-01-22 | 4 | Dillione Janet — Director | Sale (S): 10,000 @ $6.88 | EDGAR |
| 2026-01-20 | 4 | Hurlburt Elizabeth — Chief Operating Officer | Tax withholding (F): 5,794 @ $7.15 | EDGAR |
| 2026-01-20 | 4 | Todisco Joseph — Chief Executive Officer, Director | Tax withholding (F): 17,417 @ $7.15 · Option exercise (M): 29,585 @ $3.38 · Tax withholding (F): 22,665 @ $6.78 · Option exercise (M): 29,585 (derivative) @ $0 | EDGAR |
| 2026-01-15 | 4 | Seckler Michael David — Chief Commercial Officer | Grant/award (A): 133,156 @ $0 | EDGAR |
| 2026-01-14 | 4 | Lefkowitz Steven W — Director | Option exercise (M): 15,000 @ $5.63 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Hurlburt Elizabeth — Chief Operating Officer | Tax withholding (F): 10,895 @ $12.16 | EDGAR |
| 2026-01-06 | 4 | Zelnick Kaufman Beth — Chief Legal Officer | Tax withholding (F): 11,333 @ $12.16 | EDGAR |
| 2026-01-02 | 4 | DUNTON ALAN W — Director | Option exercise (M): 20,000 @ $4.03 · Sale (S): 20,000 @ $13 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2025-12-19 | 4 | Todisco Joseph — Chief Executive Officer, Director | Option exercise (M): 30,000 @ $4.43 · Sale (S): 30,000 @ $12 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2025-12-11 | 4 | Dillione Janet — Director | Option exercise (M): 19,000 @ $9.55 · Option exercise (M): 15,000 @ $5.63 · Sale (S): 34,000 @ $12 · Option exercise (M): 19,000 (derivative) @ $0 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | Lefkowitz Steven W — Director | Sale (S): 40,000 @ $11.88 | EDGAR |
| 2025-12-04 | 4 | Dillione Janet — Director | Option exercise (M): 12,210 @ $4.03 · Option exercise (M): 15,124 @ $4.43 · Option exercise (M): 19,323 @ $3.55 · Sale (S): 46,657 @ $10 · Option exercise (M): 12,210 (derivative) @ $0 · Option exercise (M): 15,124 (derivative) @ $0 · +1 more | EDGAR |
| 2025-11-26 | 4 | Dillione Janet — Director | Option exercise (M): 8,000 @ $2.85 · Option exercise (M): 7,790 @ $4.03 · Option exercise (M): 4,876 @ $4.43 · Option exercise (M): 5,677 @ $3.55 · Sale (S): 26,343 @ $9.93 · Option exercise (M): 8,000 (derivative) @ $0 · +3 more | EDGAR |
| 2025-11-18 | 4 | Dillione Janet — Director | Sale (S): 30,000 @ $11.42 | EDGAR |
| 2025-10-27 | 4 | Kaplan Myron — Director | Purchase (P): 25,000 @ $11.02 | EDGAR |
| 2025-09-18 | 4 | Duncan Gregory Scott — Director | Option exercise (M): 13,333 @ $8.32 · Option exercise (M): 13,333 (derivative) @ $0 | EDGAR |
| 2025-09-16 | 4 | DUNTON ALAN W — Director | Option exercise (M): 10,000 @ $3.55 · Sale (S): 10,000 @ $13.13 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2025-09-12 | 4 | Todisco Joseph — Chief Executive Officer | Option exercise (M): 50,000 @ $3.47 · Sale (S): 50,000 @ $13 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2025-09-12 | 4 | Todisco Joseph — Chief Executive Officer | Tax withholding (F): 21,225 @ $11.66 | EDGAR |
| 2025-09-11 | 4 | Zelnick Kaufman Beth — Chief Legal Officer | Option exercise (M): 50,000 @ $3.30 · Sale (S): 49,600 @ $13.41 · Sale (S): 400 @ $12.82 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2025-09-11 | 4 | Hurlburt Elizabeth — Chief Operating Officer | Option exercise (M): 12,876 @ $1.45 · Sale (S): 12,876 @ $13.51 · Option exercise (M): 41,121 @ $1.45 · Sale (S): 41,121 @ $13.08 · Option exercise (M): 12,876 (derivative) @ $0 · Option exercise (M): 41,121 (derivative) @ $0 | EDGAR |
| 2025-09-08 | 4/A | Hurlburt Elizabeth — Chief Operating Officer | Tax withholding (F): 8,424 @ $14.83 | EDGAR |
| 2025-09-08 | 4/A | Zelnick Kaufman Beth — Chief Legal Officer | Tax withholding (F): 8,880 @ $14.83 | EDGAR |
| 2025-09-03 | 4 | Hurlburt Elizabeth — Chief Operating Officer | Grant/award (A): 69,686 @ $0 | EDGAR |
| 2025-09-03 | 4 | Zelnick Kaufman Beth — Chief Legal Officer | Grant/award (A): 69,686 @ $0 | EDGAR |
| 2025-09-03 | 4 | Blum Susan — Chief Financial Officer | Grant/award (A): 69,686 @ $0 | EDGAR |
| 2025-04-03 | 4 | Lefkowitz Steven W — Director | Option exercise (M): 20,000 @ $4.03 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Todisco Joseph — Chief Executive Officer, Director | Option exercise (M): 59,170 @ $3.38 · Option exercise (M): 59,170 (derivative) @ $0 | EDGAR |
Recent 8-K events — CorMedix Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-07 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-02 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-07-01 | 8-K | 4.01 — Changes in Registrant's Certifying Accountant | EDGAR |
| 2026-06-24 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-06-08 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-27 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-06 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CRMD returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →